Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

Benzodiazepines and Alzheimer's Risk

Benzodiazepine use is associated with an increased risk of Alzheimer's disease.

Wrist Device Helps Parkinson's Patients

The first wrist-worn device has received FDA approval to assess and monitor symptoms of Parkinson's disease that impact movement.

Blood Type and Cognitive Impairment

Blood group AB and higher factor VIII are associated with increased incidence of cognitive impairment.

Fish Oil for Drug-Resistant Epilepsy

For patients with drug-resistant epilepsy, low-dose fish oil can reduce seizures compared with placebo.

MS Symptoms Worsen with Salt

High sodium intake is associated with increased disease activity in multiple sclerosis (MS).

Breathalyzer to Detect Concussions?

Researchers have proposed a breathalyzer test that could detect chemicals present in athletes’ breath that indicate a brain injury.

Brain Workaround for Alzheimer's

Scientists believe that they may have discovered why some individuals with beta-amyloid buildup retain normal cognitive function.

News

Parkinson's Meds May Spur Compulsive Behaviors

Medications commonly used to treat Parkinson's disease may raise the risk of impulse control disorders such as compulsive gambling, compulsive shopping, and/or hypersexuality.

More Safety, Efficacy Data for MS Drug Aubagio

Genzyme announced that the Food and Drug Administration (FDA) has approved the inclusion of clinical data from the TOWER and TOPIC studies of Aubagio (teriflunomide).

Diagnostic Assessment Accurately IDs Delirium in Three Minutes

A three-minute diagnostic assessment (3D-Confusion Assessment Method [CAM]) has high sensitivity and specificity for identifying delirium, according to a new study.

Fycompa sNDA Under Review for Primary Generalized Tonic-Clonic Seizures

The FDA has accepted for review the Supplemental New Drug Application (sNDA) for Fycompa (perampanel; Eisai) for the treatment of primary generalized tonic-clonic (PGTC) seizures.

FEATURES

Parkinson's Meds May Spur Compulsive Behaviors

Parkinson's Meds May Spur Compulsive Behaviors

Medications commonly used to treat Parkinson's disease may raise the risk of impulse control disorders such as compulsive gambling, compulsive shopping, and/or hypersexuality.

More Safety, Efficacy Data for MS Drug Aubagio

More Safety, Efficacy Data for MS Drug Aubagio

Genzyme announced that the Food and Drug Administration (FDA) has approved the inclusion of clinical data from the TOWER and TOPIC studies of Aubagio (teriflunomide).

Diagnostic Assessment Accurately IDs Delirium in Three Minutes

Diagnostic Assessment Accurately IDs Delirium in Three Minutes

A three-minute diagnostic assessment (3D-Confusion Assessment Method [CAM]) has high sensitivity and specificity for identifying delirium, according to a new study.

Featured courses from mycme

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular DisordersExternal web site

Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative ...

CME 31.50 Credits

UCLA Review of Clinical NeurologyExternal web site

Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...

CME 23.00 Credits

Clinicians Explore EV-D68, Paralysis LinkExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters